Hepatocyte growth factor enhances the clearance of a multidrug‐resistant Mycobacterium tuberculosis strain by high doses of conventional chemotherapy, preserving liver function-Reference-Cited by-同舟云学术

Hepatocyte growth factor enhances the clearance of a multidrug‐resistant Mycobacterium tuberculosis strain by high doses of conventional chemotherapy, preserving liver function

Published:2019-07-08 Issue:2 Volume:235 Page:1637-1648
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Bello‐Monroy Oscar¹²,Mata‐Espinosa Dulce³,Enríquez‐Cortina Cristina¹²,Souza Verónica²⁴,Miranda Roxana U.²⁴,Bucio Leticia²⁴,Barrios‐Payán Jorge³,Marquina‐Castillo Brenda³,Rodríguez‐Ochoa Ignacio²,Rosales Patricia¹,Gutiérrez‐Ruiz María Concepción²⁴^ORCID,Hernández‐Pando Rogelio³,Gomez‐Quiroz Luis Enrique²⁴^ORCID

Affiliation:

1. Posgrado en Biología Experimental, DCBS Universidad Autónoma Metropolitana Iztapalapa Mexico City Mexico

2. Laboratorio de Fisiología Celular, Departamento de Ciencias de la Salud Universidad Autónoma Metropolitana Iztapalapa Mexico City Mexico

3. Departamento de Patología Experimental Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ) Mexico City Mexico

4. Laboratorio de Medicina Experimental, Unidad de Medicina Translacional, Instituto de Investigaciones Biomédicas UNAM/Instituto Nacional de Cardiología Ignacio Chavez Mexico City Mexico

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.29082

Reference36 articles.

1. New drugs for the treatment of Mycobacterium tuberculosis infection

2. Recent developments of c‐Met as a therapeutic target in hepatocellular carcinoma;Bouattour M.;Hepatology (Hoboken NJ United States),2018

3. Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes